Spinifex Pharmaceuticals Appoints Neuroscience Expert Dr Ronald Marcus As Chief Medical Officer

MELBOURNE, Australia and STAMFORD, Connecticut, June 3, 2014 /PRNewswire via COMTEX/ -- MELBOURNE, Australia and STAMFORD, Connecticut, June 3, 2014 /PRNewswire/ --

Spinifex Pharmaceuticals, a pain drug development company, today announces that it has appointed Dr Ronald Marcus as Chief Medical Officer. Dr Marcus will be responsible for driving the development of Spinifex's lead candidate EMA401 and the Company's pre-clinical pipeline. He takes up his position immediately.

Help employers find you! Check out all the jobs and post your resume.